Your browser doesn't support javascript.
loading
Identification of Recurrent Mutations in the microRNA-Binding Sites of B-Cell Lymphoma-Associated Genes in Follicular Lymphoma.
Larrea, Erika; Fernandez-Mercado, Marta; Guerra-Assunção, José Afonso; Wang, Jun; Goicoechea, Ibai; Gaafar, Ayman; Ceberio, Izaskun; Lobo, Carmen; Okosun, Jessica; Enright, Anton J; Fitzgibbon, Jude; Lawrie, Charles H.
Affiliation
  • Larrea E; Molecular Oncology Group, Biodonostia Research Institute, 20014 San Sebastián, Spain.
  • Fernandez-Mercado M; Chinese Institute for Brain Research (CIBR), Beijing 102206, China.
  • Guerra-Assunção JA; School of Life Sciences, Tsinghua University, Beijing 100084, China.
  • Wang J; Molecular Oncology Group, Biodonostia Research Institute, 20014 San Sebastián, Spain.
  • Goicoechea I; Biomedical Engineering, School of Engineering, University of Navarra, 20014 San Sebastian, Spain.
  • Gaafar A; Great Ormond Street Institute of Child Health, University College London (UCL), London WC1N 1EH, UK.
  • Ceberio I; Barts Cancer Institute, Queen Mary University of London, London EC1M 6BE, UK.
  • Lobo C; Molecular Oncology Group, Biodonostia Research Institute, 20014 San Sebastián, Spain.
  • Okosun J; Multiple Myeloma Group, Centro de Investigación Médica Aplicada (CIMA), Pamplona, 31008 Navarra, Spain.
  • Enright AJ; Department of Pathology, Cruces Hospital, 48903 Bilbao, Spain.
  • Fitzgibbon J; Hematology Department, Hospital Universitario Donostia, 20014 San Sebastián, Spain.
  • Lawrie CH; Department of Pathology, Hospital Universitario Donostia, 20014 San Sebastián, Spain.
Int J Mol Sci ; 21(22)2020 Nov 20.
Article in En | MEDLINE | ID: mdl-33233721
ABSTRACT
Follicular lymphoma (FL) is a common indolent B-cell lymphoma that can transform into the more aggressive transformed FL (tFL). However, the molecular process driving this transformation is uncertain. In this work, we aimed to identify microRNA (miRNA)-binding sites recurrently mutated in follicular lymphoma patients, as well as in transformed FL patients. Using whole-genome sequencing data from FL tumors, we discovered 544 mutations located in bioinformatically predicted microRNA-binding sites. We then studied these specific regions using targeted sequencing in a cohort of 55 FL patients, found 16 recurrent mutations, and identified a further 69 variants. After filtering for QC, we identified 21 genes with mutated miRNA-binding sites that were also enriched for B-cell-associated genes by Gene Ontology. Over 40% of mutations identified in these genes were present exclusively in tFL patients. We validated the predicted miRNA-binding sites of five of the genes by luciferase assay and demonstrated that the identified mutations in BCL2 and EZH2 genes impaired the binding efficiency of miR-5008 and miR-144 and regulated the endogenous levels of messenger RNA (mRNA).
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Binding Sites / Lymphoma, Follicular / Lymphoma, Large B-Cell, Diffuse / Proto-Oncogene Proteins c-bcl-2 / MicroRNAs / Enhancer of Zeste Homolog 2 Protein Type of study: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Country/Region as subject: Europa Language: En Journal: Int J Mol Sci Year: 2020 Document type: Article Affiliation country: España

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Binding Sites / Lymphoma, Follicular / Lymphoma, Large B-Cell, Diffuse / Proto-Oncogene Proteins c-bcl-2 / MicroRNAs / Enhancer of Zeste Homolog 2 Protein Type of study: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Country/Region as subject: Europa Language: En Journal: Int J Mol Sci Year: 2020 Document type: Article Affiliation country: España
...